Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1148 of 5804
-
New RSV drug trial aims to protect vulnerable adults
Disease control Recruiting nowThe main purpose of this study is to investigate the antiviral effect of S-337395 compared with placebo among nonhospitalized adult participants with high-risk factors for progression to severe RSV infection starting intervention within 72 hours of RSV symptom onset.
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Shorter radiation course for sarcoma shows promise in new trial
Disease control Recruiting nowBased upon the preliminary data derived from first SCOPES clinical trial and the results of patients treated during the recent COVID-19 pandemic, patients with soft tissue sarcomas (STS) can be preoperatively irradiated in a modestly hypofractionated schedule of 14 x 3 Gy. From a…
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Sound waves aim to quiet fibromyalgia pain
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time …
Phase: NA • Sponsor: SPIRE Therapeutics Inc. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New study tests biologic drug guselkumab for ulcerative colitis in chinese patients
Disease control Recruiting nowThe purpose of this study is to assess the measurable changes in health, function, or quality of life (clinical outcomes) after receiving guselkumab in real-world clinical practice amongst Chinese participants with ulcerative colitis (UC; a long-term disease of the large intestin…
Sponsor: Xian-Janssen Pharmaceutical Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Stem Cell-Derived 'Living Drug' takes aim at tough autoimmune conditions
Disease control Not yet recruitingThis study primarily involves the use of BCT301, an anti-CD19 Chemically induced pluripotent stem cell (CiPSC)-derived CAR-iT cells, for the treatment of patients with refractory autoimmune diseases, aiming to evaluate its safety, tolerability, and dose-limiting toxicities(DLT), …
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Prune power: could 5 prunes a day save your bones?
Prevention Recruiting nowDietary interventions of prune consumption during the transmenopausal period are innovative methods to prevent bone loss. Modern medicine does not intervene to prevent or attenuate this highly vulnerable period of bone loss which, if successfully attenuated, can potentially preve…
Phase: NA • Sponsor: Penn State University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
Can acupuncture and exercise ease pelvic pain during pregnancy?
Symptom relief CompletedStudy's Objective: this study aimed to discover the effect of combining electroacupuncture with therapeutic exercises on of symphysis pubis dysfunction during pregnancy.A prospective randomized controlled trial that compared 2 groups of participants was executed. 60 primipara and…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
Smart sensors and AI aim to spot pregnancy diabetes sooner
Knowledge-focused Not yet recruitingGestational diabetes mellitus (GDM), as the most common metabolic complication of pregnancy, poses a serious threat to maternal and fetal metabolic health. However, current GDM diagnosis faces several problems such as static, single-point, cumbersome to operate and delayed diagno…
Sponsor: Peking Union Medical College Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New cell therapy takes aim at Hard-to-Treat multiple myeloma
Disease control Recruiting nowThis is a prospective, single-arm, open-label dose-escalation clinical study to evaluate LVIVO-TaVec200 in the treatment of relapsed/refractory multiple myeloma.
Phase: EARLY_PHASE1 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a new pill tame immunotherapy's worst side effects and let patients restart treatment?
Disease control Not yet recruitingThis study is a Phase II, two-cohort, multicenter, two-stage clinical trial. It plans to enroll 72 subjects with solid tumors who discontinued prior ICI therapy due to irAE. Cohort 1 enrolls subjects with irAE resistant to or dependent on corticosteroid therapy. Subjects in Cohor…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a single shot stop c. diff from returning?
Prevention Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 18 years of age and above.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Radioactive injection targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study is an open, multicenter, dose-escalation and cohort-expansion non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of Lutetium \[177Lu\] BL-ARC001 in patients with locally advanced or metas…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Gout and obesity: new trial tests Weight-Loss drug to lower uric acid
Disease control Not yet recruitingA total of 120 obese gout patients were included in a 24-week double-blind randomized controlled design. The intervention group received orlistat 120 mg tid + UTL + individualized diet-exercise-behavioral reinforcement weight loss program, while the control group received a place…
Phase: NA • Sponsor: XueMei Guo • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New pill aims to tame ulcerative colitis Flare-Ups
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a simple protein infusion boost stroke recovery?
Disease control Not yet recruitingAlbumin-assisted therapy has demonstrated good safety and potential neuroprotective effects following mechanical thrombectomy. To further systematically evaluate its efficacy and safety, we are conducting a Phase IIa clinical trial of intra-arterial albumin administration combine…
Phase: PHASE2 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New combo therapy shows promise for tough bile duct cancer
Disease control Recruiting nowThis prospective real-world study aims to evaluate the effectiveness and safety of an alternating treatment regimen combining hepatic arterial infusion chemotherapy (HAIC) with systemic chemotherapy, with or without adebrelimab and apatinib, in patients with unresectable biliary …
Phase: PHASE2 • Sponsor: Air Force Military Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple drug cut repeat brain bleed surgeries?
Disease control Recruiting nowThis study is an open label randomized controlled trial. Patients with a symptomatic Chronic Subdural Hematoma (CSDH) confirmed on radiological imaging, planned for surgery, age over 18, free from other intracranial pathologies and no previous intracranial surgery, will be recrui…
Phase: PHASE2, PHASE3 • Sponsor: St. Olavs Hospital • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Home HIV tests and PrEP during TB checks could boost prevention
Prevention Recruiting nowThis household randomized implementation study assesses the implementation and effectiveness of home-based HIV self- testing and PrEP initiation versus standard clinic referral for PrEP initiation during modified standard-of-care (modified SOC) household TB contact investigation …
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Could 3 radiation sessions be enough for prostate cancer?
Disease control Recruiting nowHypofractionated radiosurgery with 5 fractions is considered standard of care for localized prostate cancer. The investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 3 fractions in patients wit…
Phase: NA • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New daily pill aims to boost growth in kids with dwarfism
Disease control Not yet recruitingThis is a multicenter, non-randomized, open-label, phase I/II study in children with ACH. This study will start with a dose escalation of ABSK061 in children with ACH to evaluate the safety, tolerability, PK, and efficacy. The RDE confirmation part will evaluate the safety and ef…
Phase: PHASE1, PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC